Business
Oxford-AstraZeneca vaccine is cheaper than Pfizer’s and Moderna’s and doesn’t require supercold temperature – The Conversation US
There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the…
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 and it has several advantages over those of its competitors, Pfizer and Moderna.
On Monday, AstraZeneca released interim analysis of its phase 3 trial data of 23,000 volunteers from the U.K. and Brazil. These results show that the test vaccine is between 70% and 90% effective in stopping COVID-19, depending on the vaccine doses administered. Although less effective than…
-
Noosa News21 hours agoBlute’s Bar Is Picking Up Where The Bearded Lady Left Off, Adding Live Music to Its Late-Night Karaoke Sing-Alongs
-
General21 hours ago‘You worry’: fears in Iranian community after bombing
-
Noosa News22 hours agoBrawl at busy intersection at Ashmore on the Gold Coast ends in heavy fines
-
Business21 hours ago3 ASX 200 shares to buy for the year ahead